nimodipine has been researched along with Encephalopathy, Toxic in 8 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Calpain activity in brain increased by 40% in TOCP hens compared to the control group when measured 24h after dosing and remained high (18% over control) 21 days after dosing." | 1.38 | Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: ameliorative effects using control of calcium homeostasis. ( Deoliveira, GH; Ehrich, M; Emerick, GL; Jortner, BS; Oliveira, RV, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasternak, JJ | 1 |
| Lanier, WL | 1 |
| Li, X | 1 |
| Rose, SE | 1 |
| Montine, KS | 1 |
| Keene, CD | 1 |
| Montine, TJ | 1 |
| Emerick, GL | 1 |
| Ehrich, M | 1 |
| Jortner, BS | 1 |
| Oliveira, RV | 1 |
| Deoliveira, GH | 1 |
| Choudhary, S | 2 |
| Raheja, G | 1 |
| Gupta, V | 1 |
| Gill, KD | 2 |
| Thom, SR | 1 |
| Fisher, D | 1 |
| Zhang, J | 1 |
| Bhopale, VM | 1 |
| Cameron, B | 1 |
| Buerk, DG | 1 |
| Düzenli, S | 1 |
| Bakuridze, K | 1 |
| Gepdiremen, A | 1 |
| Li, N | 1 |
| Liu, B | 1 |
| Dluzen, DE | 1 |
| Jin, Y | 1 |
2 reviews available for nimodipine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Neuroanesthesiology update.
Topics: Anesthesia; Anesthesiology; Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Electroenceph | 2010 |
Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitro.
Topics: Amyloid beta-Peptides; Animals; Blotting, Western; Calcium Channel Blockers; Cell Line, Tumor; Cells | 2013 |
6 other studies available for nimodipine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: ameliorative effects using control of calcium homeostasis.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Brain; Calcium; Calcium Gluconate; Calpain; Car | 2012 |
Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity.
Topics: Animals; Calcium Channel Blockers; Dichlorvos; Dopamine; Dopamine beta-Hydroxylase; Injections, Subc | 2002 |
Neuronal nitric oxide synthase and N-methyl-D-aspartate neurons in experimental carbon monoxide poisoning.
Topics: Animals; Brain Chemistry; Calcium Channel Blockers; Carbon Monoxide Poisoning; Cyclic GMP; Dizocilpi | 2004 |
The effects of ruthenium red, dantrolene and nimodipine, alone or in combination, in NMDA induced neurotoxicity of cerebellar granular cell culture of rats.
Topics: Animals; Calcium; Cells, Cultured; Cerebellum; Dantrolene; N-Methylaspartate; Neuroprotective Agents | 2005 |
Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Calcium; Calcium Channel | 2007 |
Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain(1).
Topics: Animals; Brain; Calcium; Calcium-Binding Proteins; Calpain; Carboxylic Ester Hydrolases; Cholinester | 2001 |